Stay updated on Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6 on the page, indicating a newer version of the ClinicalTrials.gov entry. This reflects a page refresh or minor metadata update without altering the study details.
    Difference
    0.1%
    Check dated 2026-08-30T22:31:07.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5, signaling a minor patch. No visible study details or core functionality are affected.
    Difference
    0.0%
    Check dated 2026-08-09T11:06:58.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a software update. The underlying study information and user-facing content remain unchanged.
    Difference
    0.0%
    Check dated 2026-07-25T17:49:04.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Footer text now includes Moffitt center branding and a new revision tag (v3.6.3). The old revision tag (v3.6.2) was removed.
    Difference
    0.2%
    Check dated 2026-07-04T13:13:06.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.2 from v3.6.0, signaling a new version of the page metadata. This update reflects documentation/version control activity rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-06-27T06:39:51.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Recruitment status now indicates no participant enrollment; new sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading was adjusted with a revision note updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T00:30:49.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.